JP Morgan Chase’s La Jolla Pharmaceutical Company LJPC Stock Holding History

JP Morgan Chase’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-54,000	Closed	-$1.61M	–	5909
2018 Q1	$1.61M	Buy	+54,000	New	+$1.74M	﹤0.01%	3407

JP Morgan Chase's LJPC Position: Q3 2022 in Review

JP Morgan Chase sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 47 shares.

JP Morgan Chase first reported a position in LJPC in Q4 2016 and held it in 20 quarters. The position peaked at $4.08M in Q1 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

JP Morgan Chase reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
JP Morgan Chase sold 47 La Jolla Pharmaceutical Company shares in Q3 2022.
JP Morgan Chase first reported a position in La Jolla Pharmaceutical Company in Q4 2016 and held it in 20 quarters.
JP Morgan Chase's La Jolla Pharmaceutical Company position peaked at $4.08M in Q1 2018.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.